Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer

Published:2023-07 Issue: Volume:566 Page:216244
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Zhang Yunyan^ORCID,Fan Aoyu,Li Yunpeng,Liu Zhuolin^ORCID,Yu Liu,Guo Jianming,Hou Jun,Li Xiaobo,Chen Wei^ORCID

Funder

Shanghai Municipal Health Bureau

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA. Cancer J. Clin.,2021

2. Treatment of advanced prostate cancer;Teo;Annu. Rev. Med.,2019

3. Genetics and biology of prostate cancer;Wang;Genes Dev.,2018

4. Tumor microenvironment-derived NRG1 promotes antiandrogen resistance in prostate cancer;Zhang;Cancer Cell,2020

5. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation;Chen;Cancer Lett.,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNA hsa_circ_0001610 promotes prostate cancer progression by sponging miR-1324 and upregulating PTK6;Gene;2024-12

2. The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives;Cancer Letters;2024-11

3. Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analyses;Cancer Letters;2024-11

4. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

5. Integrative bioinformatics approach yields a novel gene expression risk model for prognosis and progression prediction in prostate cancer;Journal of Cellular and Molecular Medicine;2024-06